This bill mandates that Medicare Advantage plans report the allowed amount, member cost-sharing, and details regarding at-home health risk assessments in their encounter data starting in 2027.
Diana DeGette
Representative
CO-1
The Medicare Advantage Cost Transparency Act mandates that Medicare Advantage plans report detailed financial information, including contracted rates and member cost-sharing amounts, within their encounter data starting in 2027. This legislation also requires plans to disclose whether their members received specific types of at-home health risk assessments during the plan year. The goal is to increase transparency regarding costs and assessment activities within Medicare Advantage plans.
The Medicare Advantage Cost Transparency Act is pulling back the curtain on the financial inner workings of private Medicare plans. Starting January 1, 2027, Medicare Advantage (MA) organizations will be required to include granular financial data in their 'encounter data'—the records they send to the government every time a member gets a checkup or a procedure. Specifically, plans must report the 'allowed amount' (the actual price they negotiated with the doctor) and the exact amount of cost-sharing the patient paid out of pocket. This moves the needle from general estimates to hard numbers on what services actually cost.
For anyone who has ever been confused by an Explanation of Benefits (EOB) or wondered why the same procedure costs different amounts depending on the plan, this bill targets that exact lack of clarity. By requiring plans to report the contracted rates for every service under Section 2, the government aims to see exactly how much taxpayer money is staying with providers versus how much is being absorbed by insurance overhead. For a freelance consultant or a retail manager planning for their parents' future care, this data could eventually lead to more competitive plan pricing and a clearer understanding of which plans actually offer the best value versus just the best marketing.
A significant portion of this bill focuses on 'at-home health risk assessments.' These are the visits where a health professional comes to your house to check on you, which can sometimes be used by plans to identify more diagnoses and increase their government payments. The bill requires plans to flag whether a member had one of these assessments and, crucially, whether it was performed by a 'specified assessment entity'—an organization the insurance company actually owns or controls. By creating these specific indicators, the bill allows regulators to track if companies are using their own subsidiaries to drive up costs or if these home visits are actually translating into better care for the patient.
While the goal is transparency, the rollout won't be instant. The Secretary of Health and Human Services has until 2027 to finalize definitions for these 'assessment entities' and for plans to update their software systems to track these new data points. For the Medicare Advantage plans themselves, this means a heavier administrative lift and more rigorous compliance checks. There is a level of vagueness regarding how the government will define these entities, which could create some back-and-forth between regulators and insurance lobbyists before the 2027 deadline. For the average person, the impact won't be felt at the pharmacy counter tomorrow, but it sets the stage for a much more accountable Medicare system three years down the road.